L-type calcium channels (Cav1.2)

Assets acting on this target.

Class
Dihydropyridine calcium channel blocker
Notes
mechanism wave 2026-08-24 (PubMed co-occurrence, 34 article(s)); source: https://pubmed.ncbi.nlm.nih.gov/40414594/

By indication

L-type calcium channels (Cav1.2) drugs compared

3 drugs, stage by indication
3 drugs acting on L-type calcium channels (Cav1.2): developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Nimodipine (Nimotop)NimotopBayer, Laboratoire X.Osmall moleculeApprovedApproved in Subarachnoid Hemorrhage
Nimodipine (GTx-104)Grace Therapeuticssmall moleculePhase 3Phase 3 in Subarachnoid Hemorrhage
LercanidipineLee's Pharmaceutical, Recordatismall moleculeStage not recordedNot recorded

← all mechanisms